Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. - Wikidata - awgldk - TriplyDB

Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

http://www.wikidata.org/entity/Q34131838

about

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies Penile cancer: Clinical Practice Guidelines in Oncology Penile cancer: current therapy and future directions.Metastatic penile carcinoma - an update on the current diagnosis and treatment options.Current and future strategies in the diagnosis and management of penile cancer.Epidermal growth factor receptor-targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis.Intermediate analysis of a phase II trial assessing gemcitabine and cisplatin in locoregional or metastatic penile squamous cell carcinoma.Intraarterial chemotherapy as the first-line therapy in penile cancer Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.Penile cancer: Perspective from a Canadian tertiary care centre.Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer.Complete Remission of Locally Advanced Penile Squamous Cell Carcinoma after Multimodality Treatment.Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?Advanced penile cancer.Novel targeted therapies for the treatment of penile cancer.Multimodality imaging of penile cancer: what radiologists need to know.Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy.Challenges and controversies in the management of penile cancer.Current Management Strategy for Penile Cancer and Future Directions.Contemporary management of patients with penile cancer and lymph node metastasis.Bilateral pelvic lymph node dissection for Chinese patients with penile cancer: a multicenter collaboration study.Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.Modification of N staging systems for penile cancer: a more precise prediction of prognosis.Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.Extent of pelvic lymph node dissection in penile cancer may impact survival.Chemotherapy in penile cancer.Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma.Contemporary management of penile cancer: greater than 15 year MSKCC experience.Lymph node metastases and prognosis in penile cancer.The evolving landscape in advanced penile cancer.Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.[Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer].[Penile carcinoma: diagnosis and therapy].Clinical scenarios for neoadjuvant chemotherapy of squamous penile cancer that is clinically node positive.Contemporary role of radiotherapy in the management of penile cancer.Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery.Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.

P2860

Q26744446-F3488BE2-C433-4FE6-BEB3-8E24287B745C Q33702475-D236C746-AC17-4930-9939-5A8355F3A464 Q33718095-D56463AE-9C72-4755-AC5D-2117F2284C83 Q34043865-6061FF0F-147E-4460-AF63-4E5CC97EBB16 Q35040384-5954CA46-1F90-4BD4-8FC6-BAA826CB2CF1 Q35063817-DF55E4EF-779A-4B55-A7F6-962823FA91AA Q35544960-8957A48C-86AE-480F-89FF-84906289F71E Q35678387-8B380BA7-CEA3-4EAE-A43B-BE3C18ECFB04 Q35869498-5D55700E-3470-4E43-9127-452BBEC707E5 Q36326085-44669322-65DE-43BB-BA15-901F680921D9 Q36544819-B87EDF29-6291-4C8E-9BAA-E44C0BE2DC33 Q37323024-B062A372-D454-4315-996F-D76283F91B55 Q37429108-EF62FFFD-DF17-482A-BF3E-3050053101C2 Q37565552-F852C7ED-A2DD-4DBF-AAFF-89A74F72BB42 Q37579723-ACAC1FE5-4AC7-46AE-A4C3-A36D0A5F667D Q37658110-CF53357F-C615-48D3-96FF-5F19513B87C4 Q37911340-045C12D4-4A64-4CB7-B291-EFB805C50D31 Q38217530-18811F0C-C1D7-49DA-BD4B-738D7FD752CF Q38239406-AA105215-69B2-4921-A757-0AFDAD15C698 Q38258024-E88A4801-A3CC-42FE-97F7-8BAD1B038463 Q38268799-CFE03B8C-ADBB-4F0E-A583-F771345416BC Q38664721-4983E885-14D1-4D0D-96E7-C4AE901AE834 Q39237306-43C0FDE3-83D9-48D8-9354-A0AC48E478B8 Q39257971-32DD86CC-9BB9-4984-9F49-DF9A5A76615B Q40535607-9A0840A5-88BB-411E-B2A8-31A7A478157B Q40975339-CF3F1FC2-67A3-4D29-A96A-0BF689F169B7 Q41574298-077DBBE2-C7CA-4D21-8DFC-9760C68F5E3C Q41706002-39567751-40D0-4427-9848-AE55473CC2D3 Q41841522-2BEACF2A-C7D0-41AC-A399-BD3934966F35 Q42139227-3D1A399F-0240-4742-B1A1-833E787E7923 Q42151165-B8AC10E8-84FA-41D8-9C70-CEBAB67A2072 Q42185073-79D4F3EA-971A-4994-9A05-ED990F9B6625 Q42358603-5A163F3A-3AC4-45B0-9CF2-B29ADFF5EAB4 Q43641621-D0C5ADC6-BB38-4466-92FD-4DB1FF549F52 Q44385879-7BB36329-5E3A-4DE0-AED5-F01AEA32ACA2 Q45973751-F602BDC1-B3CC-463C-8212-21615D7F4CC0 Q47094227-9D2DA288-E714-4435-839B-E377BF9E6A10 Q47104015-A092E80F-F553-4CA3-B5E4-CA975CA52AF8 Q47111009-E9B4E58D-50B7-468D-85C3-DBDA90072846 Q47136456-664637DA-C01C-4FFE-9657-1BA15717C92D

P2860

Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

http://www.wikidata.org/entity/Q34131838

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@ast

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@en

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@nl

type

label

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@ast

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@en

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@nl

prefLabel

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@ast

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@en

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@nl

P1433

Q34131838-F3E36604-5E49-452E-A1EB-A3A543AF9232

P1476

Q34131838-782D8156-E65F-4078-8445-AAFA9D9582A9

P2093

Q34131838-0905BC26-F65C-4B69-980F-C4C40DE1326D

Q34131838-0AECA473-6A6F-4F54-A0BA-82EF7965D219

Q34131838-2C32DB74-968E-4278-AF45-56DFF21241F6

Q34131838-604FE146-B576-416D-A4EE-57F19F154F88

Q34131838-A7BE1206-03D7-4D19-9969-2DFA0FB7718E

Q34131838-C25D9D39-A98E-4B7C-B3A1-2241ECBDAC96

Q34131838-C3544249-0B5D-415F-93B6-383FABA185A1

Q34131838-DC1B83CD-8A08-4983-8B48-EE41F8462B00

Q34131838-DDC914E3-851E-4BB9-BBE7-B338D8B25983

P2860

Q34131838-16605912-13D7-4A9D-AE56-99D31A8E8162

Q34131838-319BA70B-565E-4DEF-B237-78C612651D86

Q34131838-325876A2-F00F-461B-9BB3-66598B61A6FE

Q34131838-55A43295-86D2-4C77-8F00-840A7AF11289

Q34131838-58332C38-EEEB-4A3E-8169-C6E9C9320ACB

Q34131838-79C18E37-D302-4E65-BED9-D2AC70E65859

Q34131838-945421C4-730B-45FE-A745-7AEE05DB1F69

Q34131838-99322732-16FB-488E-B295-FB7F621C9A71

Q34131838-B21EB751-33F2-4A3B-9F7A-7DF40B67CC8B

Q34131838-CDAB43FB-4F67-4D32-BB65-6F65F0FD13AF

P304

Q34131838-DACBC3FF-01BC-41DF-AC4E-27C0D0BC936A

P31

Q34131838-CF02AA93-3E28-4CF7-A15E-3471EF57070C

P356

Q34131838-15EC55F0-782C-42FB-8B94-CB954E5EB93D

P407

Q34131838-E117DD1F-220A-4C45-9397-67CB61D78BDF

P433

Q34131838-3920448D-496F-402A-B6A9-C0FAC8523D0D

P478

Q34131838-9E82136F-A95F-432C-8697-6CD525CEBD6B

P577

Q34131838-88EC5F57-3753-4323-BE8A-A0E31580BD63

P698

Q34131838-B5DD74C8-CB9E-42D2-8A58-0851691E15B8

P921

Q34131838-87A6277C-7230-461E-B639-6A54CB4BA540

P932

Q34131838-7D956204-8662-443A-A2EC-A94BB30A778E

P356

JCO.2010.29.5477

P1433

Journal of Clinical Oncology

P1476

Neoadjuvant paclitaxel, ifosfa ...... nile cancer: a phase II study.

@en

P2093

Curtis A Pettaway

http://www.w3.org/2001/XMLSchema#string

Dallas L Williams

http://www.w3.org/2001/XMLSchema#string

Danai Daliani

http://www.w3.org/2001/XMLSchema#string

Lance C Pagliaro

http://www.w3.org/2001/XMLSchema#string

Michael B Williams

http://www.w3.org/2001/XMLSchema#string

Michael Kincaid

http://www.w3.org/2001/XMLSchema#string

Peter F Thall

http://www.w3.org/2001/XMLSchema#string

Sijin Wen

http://www.w3.org/2001/XMLSchema#string

William Osai

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer statistics, 2009

Penile carcinoma: a challenge for the developing world.

Penile cancer: epidemiology, pathogenesis and prevention.

Evaluation of survival data and two new rank order statistics arising in its consideration.

Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis.

Prognostic factors in squamous cell carcinoma of the penis.

Penile cancer: relation of extent of nodal metastasis to survival.

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.

P304

3851-3857

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.29.5477

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20625118

http://www.w3.org/2001/XMLSchema#string

P921

P932

2940402

http://www.w3.org/2001/XMLSchema#string